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Abstract
Background: There is increasing evidence that vitamin D deficiency is common and has been associated with several non-bone related 
outcomes, including insulin resistance, type 2 diabetes and cardiovascular disease. The influences of gender, puberty, and adiposity on 
serum hydroxyvitamin D (25-OH-D) levels and the relationship between 25-OH-D and insulin resistance in obese children were studied.
Material and methods: Age, gender, pubertal stage, weight status (standard deviation score of body mass index: BMI-SDS, percentage 
body fat, waist circumference), 25-OH-D levels, and insulin resistance index calculated by homeostasis model assessment (HOMA-IR) 
were evaluated in 64 obese adolescents. Multivariable linear regression was used to determine factors associated with decreased serum 
25-OH-D levels and to study the relationship between 25-OH-D and HOMA-IR.  
Results: Median serum 25-OH-D level was 10.1 ng/mL (25.2 nmol/L). 14% of patients were vitamin D-sufficient (25-OH-D ≥ 20 ng/mL), 
36% had intermediate values (11–19 ng/mL), and 50% were deficient (25-OH-D ≤ 10 ng/mL). In the multivariable model, older age, pu-
berty, higher value of percentage of body fat, and the presence of acanthosis nigricans (AN) were all negatively associated with 25-OH-D. 
Lower 25-OH-D levels were also associated with higher blood glucose, insulin and HOMA-IR after adjustment for puberty and SDS-BMI. 
Summer positively correlated with 25-OH-D level. 
Conclusion: Our study confirms that obesity is a risk factor for vitamin D deficiency. Hypovitaminosis D, common in obese adolescents 
at risk for type 2 diabetes (older age, puberty, acanthosis nigricans) is associated with worse insulin resistance.
(Pol J Endocrinol 2011; 62 (6): 506–511)
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Streszczenie
Wstęp: Niedobór witaminy D jest zjawiskiem coraz bardziej powszechnym i związanym nie tylko z zaburzeniami metabolizmu kostnego, 
ale też z insulinoopornością, cukrzycą typu 2 i chorobami sercowo-naczyniowymi. Celem pracy było badanie wpływu płci, stadium pok-
witania i otyłości na stężenie 25-OH-D w surowicy oraz zależności między witaminą D a insulinoopornością u otyłych dzieci.
Materiał i metody: U 64 otyłych nastolatków oceniano wiek, płeć, stadium pokwitania, stopień otyłości i wskaźnik insulinooporności 
(HOMA-IR). Do określenia czynników wpływających na obniżenie stężenia 25-OH-D w surowicy oraz do oceny zależności między 
25-OH-D a HOMA-IR wykorzystano wielowymiarową analizę regresji.
Wyniki: Mediana stężenia 25-OH-D w surowicy wynosiła 10,1 ng/mL (25,2 mmol/L). Tylko u 14% pacjentów stężenie 25-OH-D w surowicy 
było wystarczające (≥ 20 ng/mL), u 36% wartości te wynosiły 11–19 ng/mL, u 50% stwierdzono znaczny niedobór 25-OH-D (£ 10 ng/mL). 
W wielowymiarowej analizie regresji starszy wiek, bardziej zaawansowane stadium pokwitania, większy odsetek zawartości tłuszczu 
i obecność rogowacenia ciemnego korelowały negatywnie ze stężeniem witaminy D. Niższe stężenia 25-OH-D wiązały się z wyższym 
stężeniem glukozy, insuliny i HOMA-IR przy uwzględnieniu stadium pokwitania i SDS-BMI. Okres letni pozytywnie korelował ze 
stężeniem 25-OH-D.
Wnioski: Otyłość jest czynnikiem ryzyka niedoboru witaminy D. Niedobór witaminy D powszechny u otyłych nastolatków zagrożonych 
cukrzycą typu 2 wiąże się z większą insulinoopornością. (Endokrynol Pol 2011; 62 (6): 506–511)
Słowa kluczowe: witamina D, otyłość, nastolatkowie, insulinooporność
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Introduction
Vitamin D is an important prohormone which regu-
lates ~3% of the human genome [1], so it is only to be 
expected that its deficiency may have wide-ranging ef-
fects. The most frequent and immediate clinical presen-
tations during childhood are skeletal complications such 
as genu valgum (bowed legs), fractures and radiographic 
bone features [2]. Non-specific musculoskeletal pain is 
another frequent feature, especially in adolescence [2]. 
Vitamin D deficiency in adolescent girls starting their 
reproductive life is of particular concern since a recent 
507
Endokrynologia Polska/Polish Journal of Endocrinology 2011; 62 (6)
PR
A
C
E 
O
R
Y
G
IN
A
LN
E
Finnish study showed that neonates born to mothers 
with low vitamin D status had significantly lower bone 
mineral content [1]. Moreover, this effect may continue 
into childhood [2]. 
Vitamin D deficiency may also be associated with 
several non-bone unfavourable outcomes. Other ex-
traskeletal manifestations of hypovitaminosis D may 
include malignancy [3], autoimmune diseases [4], 
multiple sclerosis and schizophrenia [5]. Additionally, 
the role of vitamin D in the pathogenesis of type 2 dia-
betes has recently been reviewed [6]. An association has 
been found between low vitamin D status and insulin 
resistance. In some studies, vitamin D supplementation 
improved insulin secretion and glucose tolerance [6, 7]. 
 The associations between serum concentration of vi-
tamin D and insulin resistance, potentially leading to type 
2 diabetes and cardiovascular diseases, have not been 
fully explored in children. In two studies, no relationship 
between low vitamin D status and insulin resistance in 
obese children was found [8, 9]; but there were several 
limitations to these studies. On the other hand, the  study 
by Reis et al. [10] showed that low serum vitamin D in 
adolescents was strongly associated with increased risk 
for fasting hyperglycaemia, hypertension, and metabolic 
syndrome, independently of adiposity.  
As data concerning the vitamin D status in obese 
children and its relation to insulin sensitivity is con-
troversial, we studied serum 25-OH-D levels in obese 
adolescents and its relationship to selected parameters 
of carbohydrates and lipids’ metabolism. Given the lack 
of consensus regarding the definition of optimal vitamin 
D status in children, it is vital to identify functional out-
comes by which to define vitamin D status. One such 
outcome is insulin sensitivity. Thus, our study examined 
the prevalence of vitamin D deficiency, as well as the 
relationship of vitamin D and insulin resistance in obese 
adolescents based on the hypothesis that low vitamin D 
status is associated with worse insulin resistance, even 
after adjusting for such important mediators of insulin 
resistance as obesity, age and puberty. 
Material and methods
Study group
The study group consisted of 64 obese adolescents (33 boys 
and 31 girls), aged 10–18 years, attending the Outpatients 
Clinic for Children with Metabolic Disorders. Obesity was 
recognised on the basis of a body mass index (BMI) above 
the 97th percentile for age and sex on the BMI percentile 
charts for Warsaw population of children and adolescents 
[11]. Children with acute or chronic infections, as well 
as children with significant medical conditions such as 
genetic syndromes, cancers, autoimmunologic diseases, 
hepatic or renal dysfunction, hormonal abnormalities or 
diabetes, were excluded. All patients were non-smokers 
without any regular medication.
The protocol of the study was approved by the Ethi-
cal Committee of the Pomeranian Medical University.  
Anthropometric and clinical measurements
Anthropometric measurements (body height and 
weight, waist circumference) were performed by 
trained personnel, with the patients wearing only light 
underwear. Standard, electronic scale and Harpender’s 
stadiometer were used to determine body weight and 
height. Body mass index (BMI) was calculated by di-
viding weight in kilograms by height in square metres 
(kg/m2). Since BMI changes with age, the BMI-SD score 
(BMI-SDS) was also calculated. The minimal abdominal 
circumference between the xiphoid process and iliac 
crest was measured to determine the waist circumfer-
ence. Because waist circumference changes with age, 
the waist-SDS was also calculated for both genders. Per-
centage body fat (% FAT) and fat mass (in kg) were 
measured using the bioimpedance method (Bioelectrical 
Impedance Analyzer Tanita 131, Japan) with an applied 
current of 0.8 mA at a fixed frequency of 50 kHz. 
Physical examination was performed to check the 
general health status, as well as for any evidence of acan-
thosis nigricans, commonly known to be a clinical marker 
of insulin resistance in obese patients. Pubertal status 
was ascertained during physical examination and clas-
sified according to Marshall and Tanner. All participants 
were pubertal, defined as Tanner stage 2 or greater. In 
girls, breast stage was used if there was a discrepancy 
between breast and pubic hair development. In boys, 
pubic hair was used if there was a discrepancy between 
genitalia and pubic hair staging.  
Ambulatory blood pressure monitoring (ABPM) was 
performed using a Mobil-O-Graph device, which uses the 
oscillometric method. Systolic (SBP) and diastolic blood 
pressure (DBP) were measured hourly between 11 p.m. 
and 7 a.m., and half-hourly between 7 a.m. and 11 p.m. 
Biochemical measurements
All blood samples were obtained between 8 a.m. and 
11 a.m. after an overnight fast. Serum 25-OH-D was 
measured using Nichols radioimmunoassay (Nichols 
Institute, San Clemente, CA, USA) with intraassay and 
interassay CVs of 4.6% to 11.5% and 8.4% to 14.0%, 
respectively. Glucose was measured with the glucose 
oxidase technique (Glucose HK Analyzer, Olympus). 
Free insulin concentration was determined by RIA 
(Pharmacia RIA kit). HbA1c was measured by the im-
munoturbimetric method. Total cholesterol (T-chol), 
HDL cholesterol (HDL-chol) and triacylglycerol (TG) 
levels were measured in serum by automated enzymatic 
procedures (Olympus). LDL cholesterol (LDL-chol) was 
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determined after separating LDL fraction from fresh 
serum by sequential ultracentrifugation, using an Olym-
pus commercial kit. The homeostasis model was used 
for assessing insulin resistance (HOMA-IR), according 
to the following formula: HOMA-IR = fasting blood 
glucose (mmol/L) × fasting insulin (μU/mL)/ 22.5 [12].
Vitamin D status
Vitamin D status was classified as: severe deficiency 
(serum 25-OH-D: ≤ 10 ng/mL); insufficiency (serum 
25-OH-D: > 10 to < 20 ng/mL); or sufficiency (serum 
25-OH-D: 20–30 ng/mL) [13].
For the purposes of analysis, we defined seasons 
by months: winter (December–May) and summer 
(June–November).
Statistical analysis
Statistical analysis was performed using the STATA 
11 software package. Means and standard deviations 
were used to summarise continuous variables that were 
normally distributed. Kolmogorov-Smirnov test was 
used to check for normality of distribution; p < 0.05 
was considered evidence of non-normality. Medians, 
minima and maxima were used to present continuous 
variables that were not normally distributed. Statisti-
cally significant differences were tested for quantitative 
items by the Student’s t-test, and for qualitative items 
by c2 test. 25-OH-D levels were correlated to degree 
of obesity (BMI-SDS, percentage of body fat), waist 
circumference, glucose, insulin, HOMA-IR as well as 
lipid profile and blood pressure by Pearson’s correlation. 
Multivariable linear regression analysis was conducted 
for the dependent variable 25-OH-D concentration, in-
cluding season of the study, age, pubertal stage, obesity 
status and HOMA-IR as independent variables. 
Results
A total of 64 adolescents were recruited; 39 (60%) were 
tested in summer, and 25 in winter. 
Clinical and biochemical characteristics of the study 
group are set out in Table I. 
Serum 25-OH-D concentration was negatively corre-
lated with most of the demographic and biochemical vari-
ables, and positively with HDL-cholesterol level. Summer 
was positively associated with 25-OH-D (Table II). 
Table I. Clinical and biochemical characteristics of study 
group (n = 64)
Tabela I. Kliniczna i biochemiczna charakterystyka badanej 
grupy (n = 64)
Age, years (mean ± SD) 14.6 ± 2.1
Studied in summer, n (%) 38 (59)
Male/female, n (%) 33 (52)/31 (48)
Tanner stage (2, 3, 4, 5) 13, 11, 6, 34
Body mass [kg] (mean ± SD) 82.6 ± 19.3
BMI-SDS, median (min, max) 3.3 (2.1, 9.2)
Percentage of fat (mean ± SD) 34.3 ± 5.0
Waist-SDS (mean ± SD) 4.0 ± 1.7
Acanthosis nigricans, n (%) 33 (52)
SBP [mm Hg] (mean ± SD) 122.9 ± 10.5
DBP [mm Hg] (mean ± SD) 78.9 ± 10.8 
25-OH-D [ng/mL] (mean ± SD) 11.9 ± 6.4
Glucose [mmol/L] (mean ± SD) 5.2 ± 0.4
Insulin [μU/mL] median (min, max) 17.8 (6.0, 56.4)
HOMA-IR median (min, max) 4.2 (1.1, 12.9) 
HbA1c (%) (mean ± SD) 5.5 ± 0.3
T-chol [mg/dL] (mean ± SD) 174.6 ± 26.3
HDL-chol [mg/dL] (mean ± SD) 47.2 ± 10.9
LDL-chol [mg/dL] (mean ± SD) 103.3 ± 30,4
TG, mg/dL [mg/mL] (mean ± SD) 124.9 ± 41.8 
Table II. Unadjusted Pearson’s correlation coefficients of 
25-OH-D and some demographic and biochemical variables*
Tabela II. Ocena zależności pomiędzy 25-OH-D a wybranymi 
demograficznymi i biochemicznymi* zmiennymi w korelacji 
Pearsona
Selected parameters 25-OH-D
r p-value
Age –0.30 0.016
Summer 0.32 0.010
Gender –0.23 0.072
Puberty –0.33 0.008
BMI-SDS –0.33 0.008
Percentage of fat –0.63 0.000
Waist-SDS –0.52 0.000
Acanthosis nigricans –0.54 0.000
SBP –0.48 0.000
DBP –0.55 0.000
Glucose –0.22 0.084
Insulin –0.53 0.000
HOMA-IR –0.54 0.000
HbA1c –0.57 0.000
T-chol –0.39 0.001
HDL-chol 0.47 0.000
LDL-chol –0.40 0.001
TG –0.39 0.002
*After adjustment for BMI-SDS and puberty
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As mentioned above, serum 25-OH-D concentration 
was within intermediate values, although in the lower 
range (Table I). Only nine (14%) obese children were 
vitamin D-sufficient (25-OH-D ≥ 20 ng/mL); 23 (36%) 
were insufficient, and 32 (50%) had severe deficiency 
(Table III).
Table III displays differences in clinical characteristics 
and results of biochemical investigations by vitamin D 
status.
The risk of vitamin D deficiency/insufficiency 
was greater in winter (25/26) than in summer (30/38; 
p = 0.078). Sex was not associated with vitamin D sta-
tus, although boys had higher mean serum 25-OH-D 
levels compared to girls (13.3 ± 7.2 vs. 10.4 ± 5.4 ng/mL; 
p = 0.07; data not shown). Pubertal stage (2–5 accord-
ing to Tanner’s scale) was not associated with vitamin 
D status (p = 0.126; data not shown).
Both vitamin D deficiency and insufficiency were 
associated with higher body mass, (but not with 
BMI-SDS), higher content of fat tissue, greater waist cir-
cumference (waist-SDS), and the presence of acanthosis 
nigricans, which was found in 97% of vitamin D deficient 
/ insufficient patients. Adolescents with vitamin D defi-
ciency and insufficiency also had higher mean systolic 
and diastolic blood pressure (Table II). 
Similarly, both vitamin D deficiency and insuf-
ficiency were associated with higher fasting insulin, 
HbA1c, total and LDL-cholesterol, triacylglycerol and 
higher HOMA-IR. 
Clinical and biochemical parameters of subjects 
were used in multivariable models with low 25-OH-D 
(≤ 10 ng/mL) concentration as a dependent variable. 
Similar models were performed for HOMA-IR. Results 
are presented in Tables IV and V, respectively.  
Age was not a predictor when puberty, a known 
modulator of insulin sensitivity, was included in the 
model.
Discussion
Several recent studies have indicated that there is 
an increased prevalence of vitamin D deficiency 
in industrialised countries [13, 14]. Low vitamin D 
status may be caused by a number of factors, includ-
ing insufficient synthesis in the skin (due to limited 
sunlight exposure) and inadequate intake or absorp-
Table III. Clinical and biochemical characteristics of subjects based on vitamin D status 
Tabela III. Kliniczna i biochemiczna charakterystyka  grupy badanej w zależności od stężenia witaminy D w surowicy
Sufficient ≥ 20 ng/mL Insufficient < 20 ng/mL Deficient ≤ 10 ng/ml p value
n (%) 9 (14) 23 (36) 32 (50)
Age, years (mean ± SD) 13.3 ± 2.5 14.8 ± 1.6 16.2 ± 2.3 0.025
Studied in winter, n (%) 1 (4) 9 (36) 16 (60) 0.078
Male/female, n (%) 7(21) / 2(7) 10(30) / 13(42) 16(49) /16(51) 0.450
Body mass, kg (mean ± SD) 67.5 ± 15.4 81.4 ± 15.6 87.8 ± 20.6 0.017
BMI-SDS (mean ± SD) 2.9 ± 0.6 3.5 ± 1.3 4.1 ± 1.7 0.086
Percentage of fat (mean ± SD) 29.3 ± 4.2 32.6 ± 4.3 36.9 ± 4.1 0.000
Waist-SDS [cm] (mean ± SD) 2.7 ± 1.0 3.4 ± 1.3 4.7 ± 1.7 0.001
Acanthosis nigricans, n (%) 1 (3) 5 (15) 27 (82) 0.000
SBP [mm Hg] (mean ± SD) 114.8 ± 8.2 119.4 ± 10.3 127.7 ± 8.9 0.000
DBP [mm Hg]  (mean ± SD) 70.4 ± 8.3 74.4 ± 10.0 84.5 ± 8.9 0.000
25-OH-D [ng/mL]  (mean ± SD) 24.1 ± 1.9 14.1 ± 2.9 6.8 ± 1.7 0.000
Glucose [mmol/L] (mean ± SD) 5.1 ± 0.2 5.3 ± 0.4 5.3 ± 0.4 0.286
Insulin [μU/mL] (mean ± SD) 13.5 ± 5.4 13.8 ± 5.5 25.7 ± 9.9 0.000
HOMA-IR  median (min, max) 3.0 ± 1.3 3.1 ± 1.4 5.9 ± 2.2 0.000
HbA1c (%)  (mean ± SD) 5.3 ± 0.2 5.4 ± 0.3 5.7 ± 0.3 0.000
T-chol [mg/dL]  (mean ± SD) 159.2 ± 38.5 168.7 ± 24.5 183.2 ± 21.0 0.019
HDL-chol [mg/dL]  (mean ± SD) 50.8 ± 9.1 54.2 ± 9.2 41.2 ± 9.2 0.000
LDL-chol [mg/dL]  (mean ± SD) 87.6 ± 37.2 95.7 ± 45.4 113.0 ± 27.2 0.027
TG, mg/dL [mg/mL] (mean ± SD) 71.4 ± 38.7 93.7 ± 45.4 162.4 ± 43.0 0.003
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tion of vitamin D. Moreover, people living at higher 
latitudes (> 35∞) — as in our country — are especially 
at increased risk for vitamin D deficiency, because in 
winter most of the UVB radiation from sunlight, which 
is required for cutaneous synthesis of vitamin D, is 
absorbed by the atmosphere and does not reach the 
earth’s surface [15]. 
The serum concentration of 25-hydroxyvitamin D, 
an indicator of vitamin D status, has been previously 
found to be low in obese adults [16]. In our study, 86% 
of subjects were identified with hypovitaminosis D, 
whereas vitamin D deficiency was observed in one 
half (50%) of obese adolescents; 36% met the defini-
tion of vitamin D insufficiency, whereas only 14% 
of the subjects were vitamin D-sufficient. Vitamin 
D-deficient patients were older and had higher body 
mass, SDS-BMI, percentage of body fat, and SDS-waist 
circumference. The low levels of 25-OH-D in obese 
adolescents in our study concur with most studies in 
children and adolescents [8, 10, 17]. The explanation for 
this association has been the sequestration of vitamin 
D in the subcutaneous fat tissue and its consequent 
reduced bioavailability [16]. Furthermore, the low 
levels of 25-OH-D may be attributed to several other 
factors such as sedentary lifestyles of obese individu-
als associated with less outdoor activities and reduced 
sunlight exposure, which may decrease endogenous 
vitamin D production and compromise vitamin D sta-
tus. Vitamin D insufficiency associated with obesity is 
likely to be functionally significant, as compensatory 
hyperparathyroidism has been observed in obese 
children and adolescents [9, 17]. It has been found 
that parathyroid hormone levels were positively, and 
25-OH-D concentrations were negatively, related to 
weight status in prepubertal children [9]. Since these 
alterations normalised after weight loss, the authors 
concluded that these changes were consequences 
rather than causes of overweight. 
It has become increasingly clear that vitamin D defi-
ciency is an important risk factor for the development of 
type 2 diabetes mellitus (DM) [6, 18, 19]. Insulin resist-
ance is a recognised precursor in the development of 
type 2 DM. It has been found that among adults without 
diabetes, vitamin D status was inversely associated with 
surrogate measures of insulin resistance [19, 20]. In our 
study, fasting insulin level and HOMA-IR were signifi-
cantly correlated with low 25-OH-D concentration, even 
after adjustment for SDS-BMI and puberty. Moreover, 
in the multivariable model, pubertal stage, percentage 
of body fat, the presence of acanthosis nigricans and 
HOMA-IR were all negatively associated with 25-OH-D 
concentration. In another model, HOMA-IR positively 
correlated with puberty and SDS-BMI, and negatively 
correlated with serum 25-OH-D levels. Similar results 
have been obtained in most studies in children and 
adolescents [10, 17, 21]. The results of a cross-sectional 
study by Kelly et al. [21] showed that vitamin D defi-
ciency is associated with worse insulin resistance in 
children, even after adjusting for obesity and puberty. 
Alemzadeh et al. [17] observed a positive relationship 
between vitamin D status and insulin sensitivity in chil-
dren and adolescents. The hypovitaminosis D subjects 
had decreased insulin sensitivity compared to vitamin 
D-sufficient patients. Moreover, serum 25-OH-D levels 
were inversely correlated with HbA1c independently of 
body adiposity, implying a higher risk for developing 
impaired glucose metabolism in children with vitamin 
D deficiency.
There are several possible mechanisms by which 
vitamin D deficiency may affect insulin sensitivity. 
Decreased vitamin D concentrations cause elevation of 
parathyroid hormone levels, which in turn affects insu-
lin sensitivity by regulating the intracellular free calcium 
concentrations in target cells. Vitamin D may also play 
a role in insulin action by stimulating the expression of 
Table IV. Results of multivariable linear regression for 
associations of patients’ characteristics with serum 25-OH-
D concentration
Tabela IV. Korelacje między wybranymi parametrami 
a stężeniem 25-OH-D w surowicy w wieloczynnikowej 
analizie regresji
Variable Partial 
b-coefficient
p value R2 for multivariable 
model
0.42
Puberty –0.37 0.003
% Fat –0.39 0.002
Acanthosis 
nigricans
–0.39 0.002
Summer 0.35 0.008
HOMA-IR –0.48 0.000
Table V. Results of multivariable linear regression for 
association of serum 25-OH-D concentration with HOMA-IR
Tabela V. Korelacja między stężeniem 25-OH-D w surowicy 
a HOMA-IR w wieloczynnikowej analizie regresji
Variable Partial 
b-coefficient
p value R2 for multivariable 
model
0.33
Puberty 0.29 0.065
BMI-SDS 0.32 0.046
25-OH-D –0.48 0.000
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insulin receptor and enhancing insulin responsiveness 
for the transport of glucose. 
The mechanism of action of vitamin D in type 
2 diabetes is suspected to be mediated not only 
through regulation of plasma calcium levels, which 
regulate insulin synthesis and secretion, but also 
through a direct action on pancreatic b-cell secretory 
function [6]. Chiu et al. [19] showed that vitamin D 
levels were negatively correlated with both first- and 
second-phase insulin responses during the hypergly-
caemic clamp and glucose levels during oral glucose 
tolerance test. They suggested that subjects with 
vitamin D deficiency not only displayed impaired 
b-cell function causing impaired glucose tolerance, 
but also were at increased risk of developing insulin 
resistance and metabolic syndrome compared to 
vitamin D-sufficient adults. 
It is commonly accepted that insulin resistance 
potentially leads to several adverse clinical and bio-
chemical outcomes known as metabolic syndrome [10, 
19, 20]. In the current study, we observed significant 
trends for a lower body mass and lower waist cir-
cumference in adolescents with higher vitamin D 
levels. Mean blood pressure (systolic and diastolic), 
insulin, HbA1c and triacylglycerol concentrations were 
also lower in those with higher levels of vitamin D. In 
contrast, subjects with lower HDL-cholesterol had also 
lower 25-OH-D levels. 
Our results are consistent with previous studies 
that have suggested that hypovitaminosis D in adults 
may influence the risk of developing hypertension 
[22], diabetes [23] and cardiovascular disease [24]. 
Few other studies have examined the relationship 
between vitamin D deficiency and risk factors of car-
diovascular disease in youth [10, 17]. Reis et al. [10], in 
a large, cross-sectional analysis including more than 
3,000 adolescents, showed that low serum 25-OH-D 
was strongly associated with hypertension, hyperg-
lycaemia, and metabolic syndrome, independently of 
body adiposity.   
Further longitudinal studies are necessary to deter-
mine whether vitamin D deficiency during childhood 
significantly predicts the occurrence of cardiovascular 
disease and type 2 DM in adulthood. 
Conclusion
Vitamin D deficiency and insufficiency are common 
among obese adolescents. Based upon current results, 
low vitamin D status is an independent predictor of 
insulin resistance, even after adjusting for SDS-BMI and 
puberty, which are known to be important mediators of 
insulin resistance. Moreover, we also found a significant 
association between vitamin D deficiency and some 
clinical and biochemical parameters of insulin resist-
ance syndrome (metabolic syndrome). The possibility 
that low vitamin D status promotes insulin resistance 
holds the promise of a simple medical intervention that 
would decrease the risk of type 2 DM and cardiovas-
cular disease.  
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